With the analysis among 913 patents, we discovered top 164 key players by total patent application. Astellas Pharma, Inc., Ganymed Pharmaceuticals AG, BioNTech Cell & Gene Therapies GmbH are dominant in this area. They take 59.04% of the total patent filing.
Tokyo-to, Japan
Patent: 170
Ganymed Pharmaceuticals AG
Rheinland-Pfalz, Germany
Patent: 139
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 45
Rheinland-Pfalz, Germany
Patent: 36
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 28
Illinois, United States
Patent: 21
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 19
Washington, United States
Patent: 15
Gyeonggi-do, South Korea
Patent: 14
With the analysis among 61 patents, we discovered top 7 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, DRAGONFLY Therapeutics, Inc., LISCure Bioscience Co. Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 19
LISCure Bioscience Co. Ltd.
Phanes Therapeutics, Inc.
California, United States
Patent: 3
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Shenzhen Xbiome Biotech Co., Ltd.
Guangdong Sheng, China
Patent: 1
New York, United States
Patent: 1
With the analysis among related 513 patents applied in the last 5 years. We discover 154 most active companies in this area. The fast-growing TRON - Translationale Onkologie an der Universitätsmedizin der, Regents of the University of California, BioNTech SE take 17.93% of patent filing during this period.
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 37
Regents of the University of California
California, United States
Patent: 31
Rheinland-Pfalz, Germany
Patent: 24
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 23
Tokyo-to, Japan
Patent: 21
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 19
Shanghai Shi, China
Patent: 14
Jiangsu Sheng, China
Patent: 14
Pennsylvania, United States
Patent: 14
Gyeonggi-do, South Korea
Patent: 14
With the analysis among related 513 patents in last 5 years, we discover 120 new entrants. DRAGONFLY Therapeutics, Inc., LaNova Medicines Ltd., Jiangnan University are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 19
Shanghai Shi, China
Patent: 14
Jiangsu Sheng, China
Patent: 14
Pennsylvania, United States
Patent: 14
Gyeonggi-do, South Korea
Patent: 14
California, United States
Patent: 12
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 12
Shanghai Escugen Biotechnology
LaNova Medicines (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 9
With the analysis among 350 patents, we discovered top 55 universities and scientific research institutions by total patent application. The Johannes Gutenberg University of Mainz, Osaka University, University of Strasbourg are dominant in this area. They take 46.29% of the total patent filing.
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 62
Osaka-fu, Japan
Patent: 29
Jiangsu Sheng, China
Patent: 14
New York, United States
Patent: 9
Nanyang Technological University
Central Region, Singapore
Patent: 7
Zhejiang Sheng, China
Patent: 7
The Johns Hopkins University
The Rockefeller University
New York, United States
Patent: 5